Announcements
- EDAP to Announce First Quarter 2024 Financial Results on May 16, 2024
- EDAP Announces Final Results from HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy to be Presented During Plenary Session at the Upcoming 119th American Urological Association (AUA) Annual Meeting
- EDAP Reports Fourth Quarter and Full-Year 2023 Financial Results
- EDAP to Announce Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024
- EDAP to Present at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
- EDAP Announces FDA Breakthrough Device Designation for Focal One® in the Treatment of Deep Infiltrating Rectal Endometriosis
- EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2023 Revenues
- EDAP Announces Completion of Enrollment in Phase 3 Study Evaluating Focal One HIFU Therapy for the Treatment of Deep Infiltrating Rectal Endometriosis
- EDAP Announces Preliminary Fourth Quarter Record Focal One® System Sales and Placements
- EDAP Appoints Ken Mobeck, Global Chief Financial Officer, and Francois Dietsch, Global Chief Accounting Officer
More ▼
Key statistics
On Friday, Edap Tms SA (EDA:STU) closed at 6.50, 74.73% above the 52 week low of 3.72 set on Nov 15, 2023.
52-week range
Open | 6.60 |
---|---|
High | 6.60 |
Low | 6.45 |
Bid | 5.25 |
Offer | 7.10 |
Previous close | 6.55 |
Average volume | 0.00 |
---|---|
Shares outstanding | 37.10m |
Free float | 12.42m |
P/E (TTM) | -- |
Market cap | 264.92m USD |
EPS (TTM) | -0.616 USD |
Data delayed at least 15 minutes, as of May 03 2024.
More ▼